IL1B and Alzheimer disease: It was also shown that IL-1β and TNFα in combination with IFNγ can exacerbate the pathology in AD due to alterations of the β-amyloid precursor protein (βAPP) metabolism resulting in triggering the production of β-amyloid peptides [83,84].